These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 20511481)

  • 1. Long-term maintenance treatment of restless legs syndrome with gabapentin enacarbil: a randomized controlled study.
    Bogan RK; Bornemann MA; Kushida CA; Trân PV; Barrett RW;
    Mayo Clin Proc; 2010 Jun; 85(6):512-21. PubMed ID: 20511481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose response of Gabapentin Enacarbil versus placebo in subjects with moderate-to-severe primary restless legs syndrome: an integrated analysis of three 12-week studies.
    VanMeter SA; Kavanagh ST; Warren S; Barrett RW
    CNS Drugs; 2012 Sep; 26(9):773-80. PubMed ID: 22849331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gabapentin enacarbil: in patients with restless legs syndrome.
    Scott LJ
    CNS Drugs; 2012 Dec; 26(12):1073-83. PubMed ID: 23179641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Gabapentin Enacarbil on Individual Items of the International Restless Legs Study Group Rating Scale and Post-sleep Questionnaire in Adults with Moderate-to-Severe Primary Restless Legs Syndrome: Pooled Analysis of 3 Randomized Trials.
    Ahmed M; Hays R; Steven Poceta J; Jaros MJ; Kim R; Shang G
    Clin Ther; 2016 Jul; 38(7):1726-1737.e1. PubMed ID: 27288210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind, placebo-controlled study to assess the efficacy and tolerability of gabapentin enacarbil in subjects with restless legs syndrome.
    Lee DO; Ziman RB; Perkins AT; Poceta JS; Walters AS; Barrett RW;
    J Clin Sleep Med; 2011 Jun; 7(3):282-92. PubMed ID: 21677899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of gabapentin enacarbil in adult patients with severe primary restless legs syndrome.
    Lee DO; Buchfuhrer MJ; Garcia-Borreguero D; Avidan AY; Ahmed M; Hays R; Ondo WG; Jaros MJ; Kim R; Shang G
    Sleep Med; 2016 Mar; 19():50-6. PubMed ID: 27198947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gabapentin Enacarbil: A Review in Restless Legs Syndrome.
    Kim ES; Deeks ED
    Drugs; 2016 May; 76(8):879-87. PubMed ID: 27146056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gabapentin enacarbil in restless legs syndrome: a phase 2b, 2-week, randomized, double-blind, placebo-controlled trial.
    Walters AS; Ondo WG; Kushida CA; Becker PM; Ellenbogen AL; Canafax DM; Barrett RW;
    Clin Neuropharmacol; 2009; 32(6):311-20. PubMed ID: 19667976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gabapentin enacarbil in Japanese patients with restless legs syndrome: a 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Inoue Y; Hirata K; Uchimura N; Kuroda K; Hattori N; Takeuchi M
    Curr Med Res Opin; 2013 Jan; 29(1):13-21. PubMed ID: 23121149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment response to sleep, pain, and mood disturbance and their correlation with sleep disturbance in adult patients with moderate-to-severe primary restless legs syndrome: Pooled analyses from 3 trials of gabapentin enacarbil.
    Bogan RK; Lee DO; Buchfuhrer MJ; Jaros MJ; Kim R; Shang G
    Ann Med; 2015 May; 47(3):269-77. PubMed ID: 25874578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized polysomnography study of gabapentin enacarbil in subjects with restless legs syndrome.
    Winkelman JW; Bogan RK; Schmidt MH; Hudson JD; DeRossett SE; Hill-Zabala CE
    Mov Disord; 2011 Sep; 26(11):2065-72. PubMed ID: 21611981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, placebo-controlled, dose-response study to assess the pharmacokinetics, efficacy, and safety of gabapentin enacarbil in subjects with restless legs syndrome.
    Lal R; Ellenbogen A; Chen D; Zomorodi K; Atluri H; Luo W; Tovera J; Hurt J; Bonzo D; Lassauzet ML; Vu A; Cundy KC
    Clin Neuropharmacol; 2012; 35(4):165-73. PubMed ID: 22664749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, double-blind, placebo-controlled study of XP13512/GSK1838262 in patients with RLS.
    Kushida CA; Becker PM; Ellenbogen AL; Canafax DM; Barrett RW;
    Neurology; 2009 Feb; 72(5):439-46. PubMed ID: 19188575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term efficacy and safety of gabapentin enacarbil in Japanese restless legs syndrome patients.
    Inoue Y; Uchimura N; Kuroda K; Hirata K; Hattori N
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):251-7. PubMed ID: 22036917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mixed treatment comparison of gabapentin enacarbil, pramipexole, ropinirole and rotigotine in moderate-to-severe restless legs syndrome.
    Sun Y; van Valkenhoef G; Morel T
    Curr Med Res Opin; 2014 Nov; 30(11):2267-78. PubMed ID: 25050588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Gabapentin Enacarbil on Quality of Life and Mood Outcomes in a Pooled Population of Adult Patients with Moderate-to-Severe Primary Restless Legs Syndrome.
    Avidan AY; Lee D; Park M; Jaros MJ; Shang G; Kim R
    CNS Drugs; 2016 Apr; 30(4):305-16. PubMed ID: 27067343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Gabapentin Enacarbil on Pain Associated with Moderate-to-Severe Primary Restless Legs Syndrome in Adults: Pooled Analyses from Three Randomized Controlled Trials.
    Hermanowicz N; Ellenbogen A; Irving G; Buchfuhrer M; Jaros MJ; Shang G; Kim R
    CNS Drugs; 2016 May; 30(5):443-54. PubMed ID: 27095237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of clinical response in a double-blind placebo controlled crossover trial of gabapentin enacarbil for restless legs syndrome.
    Winkelman JW; Jaros MJ
    Sleep Med; 2018 Aug; 48():1-7. PubMed ID: 29807228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced response to gabapentin enacarbil in restless legs syndrome following long-term dopaminergic treatment.
    Garcia-Borreguero D; Cano-Pumarega I; Garcia Malo C; Cruz Velarde JA; Granizo JJ; Wanner V
    Sleep Med; 2019 Mar; 55():74-80. PubMed ID: 30772697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gabapentin enacarbil for the treatment of restless legs syndrome (RLS).
    Burke RA; Faulkner MA
    Expert Opin Pharmacother; 2011 Dec; 12(18):2905-14. PubMed ID: 22077768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.